111 results on '"Yamaguchi, Maki"'
Search Results
102. Effects of Written and Oral Practice on L2 Learners' Acquisition of Japanese Verb Conjugations.
- Author
-
Yamaguchi, Maki
- Subjects
JAPANESE language education ,VERBS - Abstract
An abstract of the article "Effects of Written and Oral Practice on L2 Learners' Acquisition of Japanese Verb Conjugations," by Maki Yamaguchi is presented.
- Published
- 2011
103. [Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products].
- Author
-
Yamaguchi M, Takaki Y, Yamasaki Y, Oya S, Nakamura T, Morishige S, Aoyama K, Mouri F, Takase R, Matsuo Y, Osaki K, Nagafuji K, and Okamura T
- Subjects
- Female, Humans, Middle Aged, Factor VIII therapeutic use, Hemarthrosis, Immunosuppression Therapy, Hemophilia A drug therapy, Hemostatics therapeutic use
- Abstract
A 62-year-old woman was diagnosed as a hemophilia A carrier (factor VIII activity 35%) on preoperative examination of an ovarian tumor. A total of 35,600 units of recombinant factor VIII products was administered perioperatively. On postoperative day 95, a subcutaneous hematoma formed and immunosuppressive therapy with prednisolone was started based on an APTT of 66 seconds, factor VIII (FVIII) activity of 3%, and FVIII inhibitor of 1 BU/ml. During this treatment, the patient was hospitalized due to ankle joint bleeds and required hemostatic treatment, but the inhibitor disappeared and FVIII activity recovered to 30% after postoperative day 438 with cyclophosphamide. F8 analysis revealed the patient carried a heterozygosity of p.Arg391Cys, which has previously been categorized as cross-reacting material (CRM)-positive severe hemophilia A. No high-risk mutations for inhibitor development were found. We also report the results of a desmopressin acetate hydrate test administered to the patient to prepare for future treatment in case of hemorrhage, since high-dose FVIII administration may have been a factor in inhibitor development.
- Published
- 2024
- Full Text
- View/download PDF
104. Analysis of Protein Digestion and Absorption Using a Ussing Chamber to Simulate the Environment in the Digestive Tract.
- Author
-
Zhang X, Kaneko M, Liu W, Stephen OA, Nakamura K, Yamaguchi M, Yoshida C, Oishi T, Kobayashi S, Mizoi K, and Ogihara T
- Subjects
- Humans, Caco-2 Cells, Animals, Dietary Proteins metabolism, Dietary Proteins pharmacokinetics, Enteral Nutrition methods, Soy Milk chemistry, Infant, Pepsin A metabolism, Digestion physiology, Gastrointestinal Tract metabolism, Milk, Human chemistry, Milk, Human metabolism, Infant Formula chemistry, Intestinal Absorption, Whey Proteins, Milk Proteins metabolism, Milk chemistry
- Abstract
The Ussing chamber is a tool for analyzing drug absorption. We investigated whether the Ussing chamber can be used to analyze the process from digestion to absorption of protein in the gastrointestinal tract. Mixtures containing infant formula, whole cow's milk, processed soy milk, enteral nutrition, or human breast milk, were placed in the apical membrane side equipped with Caco-2 cells. After the addition of first pepsin then pancreatin, samples from the apical and basal membranes were collected. Infant formula showed the highest digestibility and absorption rate. This may be attributed to the presence of whey protein, which is rapidly digested and absorbed. The digestion and absorption of human breast milk showed different results in each donor, suggesting that digestion and absorption may vary among individuals. We concluded that the Ussing chamber can continuously analyze the process from digestion to absorption of proteins in the gastrointestinal tract.
- Published
- 2024
- Full Text
- View/download PDF
105. [Successful induction therapy for acute myeloid leukemia under management with extracorporeal membrane oxygenation].
- Author
-
Takaki Y, Yanai T, Shibata T, Honma T, Otsuka M, Yamasaki Y, Oya S, Nakamura T, Maehiro Y, Yamaguchi M, Aoyama K, Mouri F, Fukumoto Y, and Nagafuji K
- Subjects
- Humans, Female, Middle Aged, Remission Induction, Treatment Outcome, Induction Chemotherapy, Hematopoietic Stem Cell Transplantation, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Extracorporeal Membrane Oxygenation, Leukemia, Myeloid, Acute therapy, Leukemia, Myeloid, Acute complications
- Abstract
A 53-year-old woman presented with shortness of breath and hyperleukocytosis and was admitted to our hospital. Shortly after, she went into cardiopulmonary arrest and was resuscitated. Her white blood cell count was 566,000/µl, with 94.5% cup-like blasts positive for MPO staining and FLT3-ITD positive, so she was diagnosed with acute myeloid leukemia (AML) M1. She also had disseminated intravascular coagulation and tumor lysis syndrome. Extracorporeal membrane oxygenation (ECMO) was started to manage bilateral pulmonary thromboembolism that had developed due to deep vein thrombosis, and induction therapy was performed under ECMO. On the third day of illness, the patient developed cerebral hemorrhage. Hematological remission was confirmed on the 39th day of illness. After consolidation therapy with chemotherapy and an FLT3 inhibitor, she underwent allogeneic hematopoietic stem cell transplantation, and remains alive. Case reports suggest strong evidence of mortality benefit from ECMO in patients with hematologic malignancies, particularly when ECMO served as a bridge through chemotherapy. Our patient suffered from cardiopulmonary arrest due to hyperleukocytosis and pulmonary thromboembolism, but was saved by induction of remission under ECMO. Improvements in supportive care should lead to reduction in early deaths during induction therapy.
- Published
- 2024
- Full Text
- View/download PDF
106. [Allogeneic hematopoietic stem cell transplantations for relapsed and refractory acute lymphoblastic leukemia following inotuzumab ozogamicin treatment].
- Author
-
Morishige S, Yamasaki Y, Oya S, Nakamura T, Yamaguchi M, Aoyama K, Mouri F, Mizushima Y, Nakashima O, and Nagafuji K
- Subjects
- Adult, Humans, Inotuzumab Ozogamicin adverse effects, Recurrence, Remission Induction, Hematopoietic Stem Cell Transplantation adverse effects, Hepatic Veno-Occlusive Disease chemically induced, Precursor Cell Lymphoblastic Leukemia-Lymphoma complications, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy
- Abstract
Inotuzumab ozogamicin (InO) was administered in three cases of relapsed/refractory adult acute lymphoblastic leukemia (ALL) before allogeneic hematopoietic stem cell transplantation (allo-SCT). One case developed extremely severe sinusoidal obstruction syndrome (SOS) but recovered after receiving defibrotide therapy. A gap of 63 days in the SOS case was noted from the last administration of InO to allo-SCT, the duration was 133 and 86 days for the other two cases, and the remaining risk factors for SOS were comparable in the three cases. In contrast to gemtuzumab ozogamicin (GO), the interval between InO exposure and allo-SCT has not been reported as a risk for SOS. Nevertheless, this case suggests that the intervals should be as long as possible.
- Published
- 2022
- Full Text
- View/download PDF
107. [FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
- Author
-
Aoyama K, Yamasaki Y, Mouri F, Maehiro Y, Takaki Y, Oya S, Nakamura T, Morishige S, Yamaguchi M, and Nagafuji K
- Subjects
- Aged, Antigens, CD34, Female, Humans, Male, Middle Aged, Mutation, Nuclear Proteins genetics, Nucleophosmin, Prognosis, fms-Like Tyrosine Kinase 3 genetics, Leukemia, Myeloid, Acute diagnosis, Leukemia, Myeloid, Acute drug therapy, Leukemia, Myeloid, Acute genetics, Leukemia, Promyelocytic, Acute diagnosis, Leukemia, Promyelocytic, Acute drug therapy, Leukemia, Promyelocytic, Acute genetics
- Abstract
FMS-like tyrosine kinase 3 (FLT3) inhibitors improve the prognosis of FLT3-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML). Case 1 is a 47-year-old male patient who presented with a white blood cell count (WBC) of 95,700/ml with 94% blast accompanied by cuplike nuclei, lactate dehydrogenase (LDH) of 2,434 IU/l, fibrin degradation products (FDP) of 476 mg/ml, and a bone marrow examination that revealed blastic marrow with chromosome 46, XY, positive FLT3-ITD, and positive nucleophosmin 1 (NPM1) mutation type A. Flow cytometry revealed that blasts were positive for CD33 and negative for CD34, CD117, and human leukocyte antigen-DR isotype (HLA-DR). The patient had no response to idarubicin combined cytarabine; however, qiuzartinib administration resulted in the first complete remission. Case 2 is a 71-year-old female patient, who presented with 94,900/ml of WBC with a 91% blast accompanied with cup-like nuclei, LDH of 19,03 IU/l, FDP of 112 mg/ml, and a peripheral blood examination that revealed chromosome 46, XX, positive FLT3-ITD, and positive NPM1 mutation type B. Flow cytometry revealed that blasts were positive for CD33 and negative for CD34, CD117, and HLA-DR. She had a partial response to venetoclax combined with azacytidine, and qiuzartinib administration resulted in the first complete remission. Both cases were CD34- and HLA-DR-negative with disseminated intravascular coagulation mimicking acute promyelocytic leukemia (APL). Additionally, recognizing the cuplike blasts is useful to differentiate FLT3 mutant AML from APL for the proper use of FLT3 inhibitors.
- Published
- 2022
- Full Text
- View/download PDF
108. [Use of pegylated granulocyte colony-stimulating factor in dose-adjusted EPOCH-R therapy].
- Author
-
Mouri F, Yamasaki Y, Ohya S, Nakamura T, Morishige S, Yamaguchi M, Aoyama K, Seki R, Osaki K, and Nagafuji K
- Subjects
- Adult, Aged, Cyclophosphamide, Doxorubicin, Etoposide, Granulocyte Colony-Stimulating Factor, Humans, Middle Aged, Polyethylene Glycols, Prednisone, Recombinant Proteins, Retrospective Studies, Vincristine, Antineoplastic Combined Chemotherapy Protocols adverse effects
- Abstract
Dose-adjusted (DA)-EPOCH-R causes profound neutropenia requiring relatively long hospital stays with multiple doses of granulocyte colony-stimulating factor (G-CSF). A single-dose pegylated G-CSF (PEG-G-CSF) has been used for the treatment of chemotherapy-induced neutropenia. We retrospectively examined 15 patients (median age 61, range 33-75 years) treated with DA-EPOCH-R. In the first cycle of the DA-EPOCH-R therapy, a G-CSF preparation was used, and since the second cycle, the G-CSF and PEG-G-CSF use groups were divided. The median length of hospitalization after starting chemotherapy in the second-cycle DA-EPOCH-R was significantly shorter with PEG-G-CSF group (n=9) of 9 (7-13) days compared with G-CSF group (n=6) of 18 (15-22) days (P<0.001). Risk factors of febrile neutropenia, such as bone marrow invasion, performance status, serum albumin, and history of febrile neutropenia at the first DA-EPOCH-R cycle or previous chemotherapy were not significantly different for both groups, and the incidence of febrile neutropenia in PEG-G-CSF and G-CSF groups was 2.6% and 46.9%, respectively. These analyses suggest that PEG-G-CSF can be combined with DA-EPOCH-R without compromising treatment outcomes as compared with the daily dose of G-CSF.
- Published
- 2021
- Full Text
- View/download PDF
109. Insights into channel modulation mechanism of RYR1 mutants using Ca2+ imaging and molecular dynamics.
- Author
-
Yamazawa T, Ogawa H, Murayama T, Yamaguchi M, Oyamada H, Suzuki J, Kurebayashi N, Kanemaru K, Oguchi K, Sakurai T, and Iino M
- Subjects
- HEK293 Cells, Humans, Ion Channel Gating, Protein Domains, Ryanodine Receptor Calcium Release Channel chemistry, Ryanodine Receptor Calcium Release Channel genetics, Calcium metabolism, Malignant Hyperthermia genetics, Molecular Dynamics Simulation, Mutation, Ryanodine Receptor Calcium Release Channel metabolism
- Abstract
Type 1 ryanodine receptor (RYR1) is a Ca2+ release channel in the sarcoplasmic reticulum in skeletal muscle and plays an important role in excitation-contraction coupling. Mutations in the RYR1 gene cause severe muscle diseases such as malignant hyperthermia (MH), which is a disorder of CICR via RYR1. Thus far, >300 mutations in RYR1 have been reported in patients with MH. However, owing to a lack of comprehensive analysis of the structure-function relationship of mutant RYR1, the mechanism remains largely unknown. Here, we combined functional studies and molecular dynamics (MD) simulations of RYR1 bearing disease-associated mutations at the N-terminal region. When expressed in HEK293 cells, the mutant RYR1 caused abnormalities in Ca2+ homeostasis. MD simulations of WT and mutant RYR1s were performed using crystal structure of the N-terminal domain (NTD) monomer, consisting of A, B, and C domains. We found that the mutations located around the interdomain region differentially affected hydrogen bonds/salt bridges. Particularly, mutations at R402, which increase the open probability of the channel, cause clockwise rotation of BC domains with respect to the A domain by alteration of the interdomain interactions. Similar results were also obtained with artificial mutations that mimic alteration of the interactions. Our results reveal the importance of interdomain interactions within the NTD in the regulation of the RYR1 channel and provide insights into the mechanism of MH caused by the mutations at the NTD., (© 2019 Yamazawa et al.)
- Published
- 2020
- Full Text
- View/download PDF
110. [Interleukin-6-producing paraganglioma mimicking multicentric Castleman disease].
- Author
-
Oya S, Yamasaki Y, Nakamura T, Morishige S, Yamaguchi M, Aoyama K, Seki R, Mouri H, Osaki K, Naito Y, Oshima K, and Nagafuji K
- Subjects
- Adolescent, Diagnosis, Differential, Humans, Interleukin-6, Male, Posterior Leukoencephalopathy Syndrome, Vascular Endothelial Growth Factor A, Castleman Disease diagnosis, Paraganglioma diagnosis
- Abstract
Multicentric Castleman disease (MCD) comprises a heterogeneous group of lymphoproliferative disorders. Interleukin 6 (IL-6) plays an important role in the MCD pathophysiology. Here, we report the case of a 17-year-old Japanese man who presented with fever, headache, fatigue, and weight loss, with normal blood pressure. A movable mass was palpated in his lower abdomen. Laboratory tests revealed microcytic anemia and hypoalbuminemia, with elevated IL-6, sIL-2R, and vascular endothelial growth factor. Computed tomography of the abdomen demonstrated a 55-mm-diameter pelvic tumor and enlarged mesenteric lymph nodes. MCD was suspected, and the pelvic tumor resected. After the operation, his blood pressure rose slowly, and resulted to seizures of posterior reversible encephalopathy syndrome. Evaluation of hypertension revealed that plasma norepinephrine and normetanephrine concentrations were elevated, and pathological examinations showed that the resected tumor was positive for IL-6 and chromogranin-A. Therefore, we diagnosed the patient with IL-6-producing paraganglioma with MCD-mimicking symptoms. Moreover, IL-6-producing pheochromocytoma and paraganglioma should be included in differential diagnoses of MCD, even in normotensive patients.
- Published
- 2020
- Full Text
- View/download PDF
111. X-ray diffraction analysis of the effects of myosin regulatory light chain phosphorylation and butanedione monoxime on skinned skeletal muscle fibers.
- Author
-
Yamaguchi M, Kimura M, Li ZB, Ohno T, Takemori S, Hoh JF, and Yagi N
- Subjects
- Animals, Cells, Cultured, Diacetyl pharmacology, Male, Muscle Contraction drug effects, Muscle Fibers, Skeletal drug effects, Phosphorylation drug effects, Rabbits, X-Ray Diffraction methods, Diacetyl analogs & derivatives, Muscle Contraction physiology, Muscle Fibers, Skeletal physiology, Muscle Fibers, Skeletal ultrastructure, Myosin Light Chains physiology, Myosin Light Chains ultrastructure
- Abstract
The phosphorylation of the myosin regulatory light chain (RLC) is an important modulator of skeletal muscle performance and plays a key role in posttetanic potentiation and staircase potentiation of twitch contractions. The structural basis for these phenomena within the filament lattice has not been thoroughly investigated. Using a synchrotron radiation source at SPring8, we obtained X-ray diffraction patterns from skinned rabbit psoas muscle fibers before and after phosphorylation of myosin RLC in the presence of myosin light chain kinase, calmodulin, and calcium at a concentration below the threshold for tension development ([Ca(2+)] = 10(-6.8)M). After phosphorylation, the first myosin layer line slightly decreased in intensity at ∼0.05 nm(-1)along the equatorial axis, indicating a partial loss of the helical order of myosin heads along the thick filament. Concomitantly, the (1,1/1,0) intensity ratio of the equatorial reflections increased. These results provide a firm structural basis for the hypothesis that phosphorylation of myosin RLC caused the myosin heads to move away from the thick filaments towards the thin filaments, thereby enhancing the probability of interaction with actin. In contrast, 2,3-butanedione monoxime (BDM), known to inhibit contraction by impeding phosphate release from myosin, had exactly the opposite effects on meridional and equatorial reflections to those of phosphorylation. We hypothesize that these antagonistic effects are due to the acceleration of phosphate release from myosin by phosphorylation and its inhibition by BDM, the consequent shifts in crossbridge equilibria leading to opposite changes in abundance of the myosin-ADP-inorganic phosphate complex state associated with helical order of thick filaments., (Copyright © 2016 the American Physiological Society.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.